From: Prognostic factors in patients with thymoma who underwent surgery
Variable | Univariate analyses | Multivariate analyses | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 2.971 | 0.976 ~ 7.982 | 0.056 | |||
Gender | 1.462 | 0.506 ~ 4.220 | 0.483 | |||
KPS | 1.400 | 0.484 ~ 4.048 | 0.535 | |||
Smoking | 1.921 | 0.664 ~ 5.555 | 0.228 | |||
Myasthenia gravis | 2.162 | 0.757 ~ 6.181 | 0.15 | |||
Surgical approach | 1.214 | 0.418 ~ 3.525 | 0.722 | |||
Tumor size | 1.750 | 0.606 ~ 5.054 | 0.301 | |||
Resection status | 1.196 | 0.415 ~ 3.250 | 0.740 | |||
WHO classification | 2.277 | 1.040 ~ 4.987 | 0.040 | 1.906 | 0.893 ~ 4.069 | 0.096 |
Masaoka-Koga stage | 2.031 | 0.704 ~ 5.858 | 0.190 | |||
Ki-67 | 1.228 | 0.329 ~ 4.577 | 0.760 | |||
Neutrophil | 7.179 | 1.958 ~ 25.961 | 0.003 | 5.000 | 1.214 ~ 20.586 | 0.026 |
NLR | 5.646 | 1.932 ~ 16.504 | 0.002 | 2.499 | 0.727 ~ 8.590 | 0.146 |
Adjuvant radiotherapy | 0.654 | 0.219 ~ 1.959 | 0.448 | |||
Adjuvant chemotherapy | 2.256 | 0.780 ~ 6.526 | 0.133 |